Zurich Insurance Group (ZURN) H2 2021 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2021 earnings summary
17 Nov, 2026Executive summary
2021 BOP rose 35% to $5.742bn and net income attributable to shareholders increased 36% to $5.202bn, both the highest since 2007.
Growth across businesses, stronger underwriting and lower COVID-19 claims more than offset higher natural catastrophe and weather-related claims.
Total revenues were $69.867bn vs. $59.001bn; basic EPS increased to $34.99 from $25.85.
Retail customer numbers increased by 2.2m to 55.4m; estimated SST ratio reached 212%.
Financial highlights
BOP was $5.742bn vs. $4.241bn; net income attributable to shareholders was $5.202bn vs. $3.834bn.
Gross written premiums and policy fees rose to $55.777bn from $50.555bn; net earned premiums and policy fees were $43.031bn vs. $39.944bn.
Net investment result increased 2% to $7.085bn; net investment income was $5.047bn vs. $4.903bn, and net investment return was 3.5% vs. 3.4%.
Diluted EPS rose 32% to CHF 31.68; shareholders’ equity was $37.881bn, down 1% year over year.
Operating cash flow was $3.167bn vs. $5.701bn; year-end cash and cash equivalents totaled $9.330bn vs. $11.726bn.
Outlook and guidance
Expected to meet or exceed all 2022 targets; the stated SST ratio target was 160% or above.
Planned Italian life and pension back-book sale to GamaLife was expected to add 11 percentage points to SST; completion expected in H2 2022, subject to regulatory approval.
Latest events from Zurich Insurance Group
- Beazley scales Specialty as targets, synergies and AI productivity advance.ZURN
Investor Day 2026 - Higher earnings and BOP, despite a sharp swing in unit-linked investment results.ZURN
H2 2018 - P&C underwriting gains lifted H1 BOP 16%, with combined ratio improving to 95.1%.ZURN
H1 2019 - COVID-19 and volatile markets cut H1 earnings, while commercial growth and capital resilience held firm.ZURN
H1 2020 - BOP rose 16%, all three-year targets were exceeded, and a CHF 20 dividend was proposed.ZURN
H2 2019 - BOP rose 60%, while P&C’s 93.9% combined ratio marked a 20-year-plus low.ZURN
H1 2021 - COVID-19 and catastrophe losses cut BOP 20%, while commercial pricing strengthened.ZURN
H2 2020 - Higher BOP was offset by investment-market losses and an $8.8bn IFRS 17 opening-equity reduction.ZURN
H2 2022 - Record BOP and 23.1% BOPAT ROE supported higher shareholder returns.ZURN
H2 2023